Li D, Wang X, Li G, Zhou J, Bian L, Zhao X
NPJ Vaccines. 2025; 10(1):43.
PMID: 40025078
PMC: 11873297.
DOI: 10.1038/s41541-025-01098-w.
Yang F, Lin S, Yuan X, Shu S, Yu Y, Yang J
PLoS Pathog. 2025; 21(2):e1012923.
PMID: 39970183
PMC: 11864512.
DOI: 10.1371/journal.ppat.1012923.
Zhang Y, Zhang X, Yang X, Lv L, Wang Q, Zeng S
Autophagy. 2024; 20(12):2785-2803.
PMID: 39128851
PMC: 11587837.
DOI: 10.1080/15548627.2024.2390814.
Xu Y, Weng L, Wang X, Li M, Guo W, Liu Y
Virol J. 2024; 21(1):154.
PMID: 38978059
PMC: 11229241.
DOI: 10.1186/s12985-024-02416-9.
Luo S, Liang J, Yang G, Lu J, Chen J
J Virol. 2024; 98(7):e0069724.
PMID: 38916400
PMC: 11265286.
DOI: 10.1128/jvi.00697-24.
The human alpha7 nicotinic acetylcholine receptor is a host target for the rabies virus glycoprotein.
OBrien B, Thao S, Weber L, Danielson H, Boldt A, Hueffer K
Front Cell Infect Microbiol. 2024; 14:1394713.
PMID: 38836054
PMC: 11148329.
DOI: 10.3389/fcimb.2024.1394713.
Construction of Vero cell-adapted rabies vaccine strain by five amino acid substitutions in HEP-Flury strain.
Harada M, Matsuu A, Park E, Inoue Y, Uda A, Kaku Y
Sci Rep. 2024; 14(1):12559.
PMID: 38822013
PMC: 11143356.
DOI: 10.1038/s41598-024-63337-9.
Research progress on neutralizing epitopes and antibodies for the Rabies virus.
Shi C, Sun P, Yang P, Liu L, Tian L, Liu W
Infect Med (Beijing). 2023; 1(4):262-271.
PMID: 38075404
PMC: 10699689.
DOI: 10.1016/j.imj.2022.09.003.
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy.
Zorzan M, Castellan M, Gasparotto M, de Melo G, Zecchin B, Leopardi S
Front Immunol. 2023; 14:1186063.
PMID: 37638057
PMC: 10449259.
DOI: 10.3389/fimmu.2023.1186063.
Pseudotyped Viruses for Lyssavirus.
Wang W, Long C, Wang L, Wang Y
Adv Exp Med Biol. 2023; 1407:191-208.
PMID: 36920698
DOI: 10.1007/978-981-99-0113-5_10.
Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
Wang X, Wen Z, Cao H, Luo J, Shuai L, Wang C
J Virol. 2023; 97(2):e0161122.
PMID: 36779763
PMC: 9972945.
DOI: 10.1128/jvi.01611-22.
Transferrin Receptor Protein 1 Is an Entry Factor for Rabies Virus.
Wang X, Wen Z, Cao H, Luo J, Shuai L, Wang C
J Virol. 2023; 97(2):e0161222.
PMID: 36779762
PMC: 9972965.
DOI: 10.1128/jvi.01612-22.
Susceptibilities of CNS Cells towards Rabies Virus Infection Is Linked to Cellular Innate Immune Responses.
Feige L, Kozaki T, de Melo G, Guillemot V, Larrous F, Ginhoux F
Viruses. 2023; 15(1).
PMID: 36680128
PMC: 9860954.
DOI: 10.3390/v15010088.
Evolution of Rabies Virus Isolates: Virulence Signatures and Effects of Modulation by Neutralizing Antibodies.
Conselheiro J, Barone G, Miyagi S, Silva S, Agostinho W, Aguiar J
Pathogens. 2022; 11(12).
PMID: 36558890
PMC: 9782306.
DOI: 10.3390/pathogens11121556.
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs.
Li J, Liu Q, Liu J, Wu X, Lei Y, Li S
Virol J. 2022; 19(1):184.
PMID: 36371169
PMC: 9652961.
DOI: 10.1186/s12985-022-01919-7.
Looking at the Pathogenesis of the Rabies Lyssavirus Strain Pasteur Vaccins through a Prism of the Disorder-Based Bioinformatics.
Dhulipala S, Uversky V
Biomolecules. 2022; 12(10).
PMID: 36291645
PMC: 9599798.
DOI: 10.3390/biom12101436.
Interactions between the rabies virus and nicotinic acetylcholine receptors: A potential role in rabies virus induced behavior modifications.
Lian M, Hueffer K, Weltzin M
Heliyon. 2022; 8(9):e10434.
PMID: 36091963
PMC: 9450143.
DOI: 10.1016/j.heliyon.2022.e10434.
Lentiviral Vectors for Ocular Gene Therapy.
Arsenijevic Y, Berger A, Udry F, Kostic C
Pharmaceutics. 2022; 14(8).
PMID: 36015231
PMC: 9414879.
DOI: 10.3390/pharmaceutics14081605.
Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies.
Ng W, Fedosyuk S, English S, Augusto G, Berg A, Thorley L
Cell Host Microbe. 2022; 30(9):1219-1230.e7.
PMID: 35985336
PMC: 9605875.
DOI: 10.1016/j.chom.2022.07.014.
Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody.
Callaway H, Zyla D, Larrous F, de Melo G, Hastie K, Avalos R
Sci Adv. 2022; 8(24):eabp9151.
PMID: 35714192
PMC: 9205594.
DOI: 10.1126/sciadv.abp9151.